United StatesOptase Dry Eye Intense Drops (Glycerin 0.2%), 0.33 fl oz single-use sterile eye drops manufactured for Scope Health (NDC 72972-002-01), lots 8T98, 9T31, 9T32 (exp. 30/04/26); 2V13, 2V14, 2V15 (exp. 30/06/26); 3V35 (exp. 31/08/26); 3V36, 3V37 (exp. 30/09/26); 5V45, 5V46, 9V12 (exp. 31/03/27); 1X57, 1X70, 1X84 (exp. 31/05/27) is being recalled. The product was recalled due to a lack of assurance of sterility; it was sold nationwide in the United States.
What's being recalled
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.
Recalling firm: Scope Health, New York, NY, United States.
How to identify it
Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27.
The hazard
Lack of Assurance of Sterility
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the United States
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)